What does CUSIP 185575107 represent in this 13F holders report?

CUSIP 185575107 is the security identifier for CMTA - CLEMENTIA PHARMACEUTICALS IN - COM used to aggregate holder disclosures.

How many institutions held CMTA - CLEMENTIA PHARMACEUTICALS IN - COM in Q4 2017?

35 institutional investors reported CMTA - CLEMENTIA PHARMACEUTICALS IN - COM for Q4 2017. Use the holders table for investor-level position and value details.

CLEMENTIA PHARMACEUTICALS IN - COM (CMTA)

CUSIP: 185575107

Q4 2017 13F Holders as of 31 Dec 2017

Type / Class: Equity / COM
Total 13F shares: 21,576,868
Share change: +668,860
Total reported value: $409,527,980
Price per share: $18.98
Number of holders: 35
Value change: +$15,350,618
Number of buys: 15
Number of sells: 18

Quarterly Holders Quick Answers

What is CUSIP 185575107?
CUSIP 185575107 identifies CMTA - CLEMENTIA PHARMACEUTICALS IN - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Related Filing Research

Latest 13F filings for newly reported positions.
Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
Latest 10-Q/10-K reports for financial context tied to this issuer.
Recent insider transactions for executive and insider activity.
SEC investors directory and top value investors for manager drilldown.
Back to full security ownership history.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q1 2018
Previous quarter: Q3 2017

Recent filing periods for CUSIP 185575107:

Q2 2019 Q1 2019 Q4 2018 Q3 2018 Q2 2018 Q1 2018 Q4 2017 Q3 2017

Institutional Holders of CLEMENTIA PHARMACEUTICALS IN - COM (CMTA) as of Q4 2017

As of 31 Dec 2017, CLEMENTIA PHARMACEUTICALS IN - COM (CMTA) was held by 35 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 21,576,868 shares. The largest 10 holders included ORBIMED ADVISORS LLC, NEA Management Company, LLC, WELLINGTON MANAGEMENT GROUP LLP, JANUS HENDERSON GROUP PLC, DRIEHAUS CAPITAL MANAGEMENT LLC, JPMORGAN CHASE & CO, FEDERATED INVESTORS INC /PA/, RA CAPITAL MANAGEMENT, LLC, FMR LLC, and BlackRock Inc.. This page lists 35 institutional shareholders reporting positions in this security for the Q4 2017 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.